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INTRODUCTION 
Pituitary adenoma is a benign tumour that originates from the 
adenohypophyseal cells of the anterior lobe of pituitary gland. It accounts 
for 12% to 15% of all intracranial tumours.
1 
A spectrum of visual 
manifestations are seen with these tumours, ranging from the absence of 
any visual symptoms to severe visual field defects and loss of vision 
The clinical manifestations depend on the cell type of the tumour, 
hypo or hypersecretion of hormones, direction of local spread and 
compression of adjacent structures. 
       Pituitary adenomas are of 2 types according to the size : 
microadenomas (≤10 mm) and macroadenomas (>10 mm).3 In 
comparison to men, women have a 2-fold increased risk of developing 
pituitary adenomas. Pituitary adenoma is a benign tumour, however, it 
has a tendency of recurrence. Clinical features of adenomas are either due 
to hypersecretion or hyposecretion of hormones or compression of 
pituitary adenoma to the surrounding structures.
3
 
      Pituitary gland is situated in the sella turcica, 10–13 mm below the 
optic chiasm. Therefore, when it increases in size, it can easily compress 
the optic nerve fibres at the chiasma.  
 2 
Microadenomas can have a little effect on the optic nerve or on the 
function of other glands, whereas macroadenomas can cause significant 
visual impairment.  
Compression of the frontal part of the optic nerve, affects the 
visual fields, visual acuity, and contrast sensitivity. 
Compression of optic chiasma for a long duration can cause severe 
vision impairment due to optic atrophy.  Functioning adenomas cause less 
specific visual symptoms as they are diagnosed earlier due to hormone 
specific symptoms.  
Non-functioning pituitary adenomas cause progressive visual loss 
as they grow slowly and compress the optic chiasm.
5
 Pituitary adenomas 
are diagnosed earlier nowadays because of the availability of 
radioimmunoassay techniques for the hormones and use of CT scanning 
and MRI imaging, done for indications unrelated to suspicion of pituitary 
tumours like head injuries and evaluation of headache. 
The arrangement of fibres characteristically account for a classical 
bitemporal hemianopia, however other defects like arcuate scotomas, 
junctional defects, nasal field loss can occur.  
 3 
Other manifestations like ophthalmoplegia due to involvement of 
3,4,5,6 cranial nerves, see saw nystagmus, disturbance in depth 
perception, optic atrophy related to compression of surrounding structures 
can occur. 
  
 4 
ANATOMY OF SELLAR REGION 
Sellar region occupies most of the middle cranial fossa. Upper 
border of sella  tursica lies in the plane of floor of anterior cranial fossa. 
Boundaries 
front it is bounded by the posterior border of the lesser wing of 
sphenoid, the anterior clinoid processes and anterior margin of sulcus 
chiasmata.  Behind by the superior borders of the petrous border of the 
temporal bone and the dorsum sellae of the clinoid bone. Laterally by the 
temporal squamae, the frontal angles of the parietal bones and the greater 
wing of the sphenoid. 
Centrally the floor is formed by the body of the sphenoid. In front, 
the sulcus chiasmatis leads on each side into the optic canal, the sulcus is 
rarely in contact with optic chiasma which is usually above and behind it. 
The optic canal is between the 2 roots of lesser wing with medially the 
body of the sphenoid. 
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It extends forwards, laterally and somewhat downwards containing 
the optic nerve, ophthalmic artery and meninges. 
Immediately behind the sulcus the upper surface of body of 
sphenoid is shaped like a “Turkish saddle” and it is named as “sella 
tursica”.Its anterior slope bears a medium elevation, the tuberculum sellae 
and behind that the surface is hollowed out as hypophyseal fossa which 
contains the hypophysis cerebri. 
The floor of the hypophyseal fossa forms a part of the roof the 
sphenoidal sinus. Posterior to the fossa, a plate of bone projects upwards 
and forwards to form the dorsum sellae. On each side the superolateral 
angle of the dorsum sellae is expanded into the posterior clinoid process. 
Lateral to the sella tursica, the body of the sphenoid presents a shallow 
groove for the internal carotid artery which runs forwards from the 
foramen lacerum. 
Laterally, the middle cranial fossa is deep and supports the 
temporal lobe of the cerebrum. It is formed in the front by cerebral 
surface of the greater wing of the sphenoid, behind by the anterior surface 
of petrous part of the temporal lobe and laterally the cerebral surface of 
the temporal squama occupies interval between  these 2 bones. 
 6 
It is related in front to the apical region of the orbit, laterally to the 
temporal fossa and below to the infratemporal fossa. 
Anteriorly it communicates with the orbit through the superior 
orbital fissure. It transmits the terminal branches of the optic nerve, 
ophthalmic vein, oculomotor, trochlear and abducent nerves and some 
smaller vessels. 
The anteroposterior diameter of the sella is the greater diameter 
and is not related to any fixed landmark. 17mm is upper limit of the 
normal diameter. The depth is the greatest downward distance to the floor 
along a perpendicular line traced between tuberculum sellae and top of 
the dorsum sellae. 
However, a deeper sella may be normal. Width of the floor may be 
variable from 10 to 15 mm .Mean volume of the sellar cavity is 594 cubic 
mm. Maximum value is 1092 cubic mm. 
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Figure 1: anatomy of sellar region 
Structures present in sellar region 
1. Optic nerve 
2. Optic chiasma 
3. Optic tracts 
4. Internal carotid arteries  
5. Hypophysis  
6. Hypothalamus 
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ANATOMY OF PITUITARY GLAND 
The hypophysis lies in a depression in the roof of the body of the 
sphenoid bone .The roof of the sella is formed by a fold of duramater 
called the diaphragm sellae which stretches from the anterior to the 
posterior clinoids. 
Pituitary gland is situated in the base of the brain, and is the most 
important endocrine gland producing a number of hormones controlling 
many other endocrine glands. The stalk of the pituitary gland pierces the 
diaphragma sella and is related above to the floor of third ventricle. 
Relations  
Hypophysis cerebri is superiorly related to optic chiasma, 
tubercinerium and infundibular recess of the third ventricle and inferiorly 
related to hypophysial fossa and sphenoidal air sinuses. 
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Figure 2 :Anatomy of pituitary gland 
Embryology  
The gland has 2 main parts namely adenohypophysis ,which 
develops from the Ratkhe’s pouch and neurohypophysis which develops 
as a down growth from diencephalon . 
Adenohypophysis has an anterior lobe or pars anterior, an 
intermediate lobe or pars intermedialis and a tuberal lobe or pars tuberalis 
.The anterior lobe is the largest, the intermediate lobe is a remnant of 
Ratkhe’s pouch and the pars tuberalis is an upward extension of the 
anterior lobe and also forms a part of the infundibulum. 
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The neurohypophysis has a posterior lobe or pars posterior, an 
infundibular stem and the median eminence. 
Blood supply  
Pituitary gland is supplied by the following branches of internal 
carotid artery: 
1. Superior hypophyseal artery on each side that supply ventral part 
of hypothalamus, upper part of infundibulum and lower part of 
infundibulum through long descending branch called ,trabecular 
artery.  
2.  Inferior hypophyseal branch that divides into medial and lateral 
branches that join one another forms an arterial ring. 
3. The anterior lobe is exclusively supplied by portal vessels arising 
from capillaries from superior hypophyseal arteries. These are of 
importance as they carry hormone releasing factors from 
hypothalamus. 
Short veins on the surface of the gland drain into surrounding dural 
venous sinuses. 
 11 
There are three possible routes for venous drainage of the neuro-
hypophysis: to the adenohypophysis, via long and short portal vessels; 
into the dural venous sinuses, via the large inferior hypophysial veins; 
and to the hypothalamus, via capillaries passing to the median eminence. 
The venous drainage carries hypophysial hormones from the gland to 
their targets and also facilitates feedback control of secretion. 
             However, venous drainage of the adenohypophysis appears 
restricted: few vessels connect it directly to the systemic veins and so the 
routes by which blood leaves remain obscure.
14 
Hormones  
Anterior lobe  
1. Chromophilic cells (50%) 
 Acidophils/alpha cells( 43%) 
a. Somatotrophs secrete growth  hormones GH 
b. Mamotrophs secrete lactogenic hormone 
c. Corticotrophs secrete ACTH 
 Basophils/ beta cells (7%) 
a. Thyrotrophs secrete TSH 
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b. Gonadotrophs secrete LSH 
c. Leucototrophs secrete LH 
2. Chromophobic cells (50%) 
Represent non secretory phase of other cells  
Intermediate lobe   
Secrete MSH melanocyte stimulating hormone 
Posterior lobe  
It is composed of a number of non myelinated fibers of 
hypothalamo-hypophyseal tract and modified cells called pituicytes. 
Pituitary Adenomas with Secretory Function –  
Eosiniphilic Adenoma   
         It results in excessive secretion of growth hormone causing 
acromegaly in adults and gigantism in the young 
        General Symptoms caused by this tumour includes  
 Hands and Feet enlarged 
 Prominent Jaw 
 Increased Tongue thickness 
 Loss of Libido 
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 Amenorrhoea in females 
 Impotency in Males 
Prolactin secreting adenomas result in galactorrhoea and 
amenorrhea. 
Basophilic Adenomas 
They secrete excessive ACTH resulting in Cushing’s Syndrome 
The symptoms of this tumour includes  
 Adiposity 
 Moon Face 
 Hypertension 
 Hypogonadism 
 Osteoporosis 
Pituitary Carcinoma has been pathologically verified to be 
associated with Cushing’s Syndrome. Visual failures and field defects are 
less common with functional adenomas than with non-functional 
adenomas. 
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Non Secretory Pituitary Adenomas  
Chromophobe Adenomas  
It is a highly common intracranial tumour. This tumour flattens and 
compresses the pituitary glands against the wall of the sella producing 
hypo-pituitarism. Only 50 % of the patients clinically manifest  endocrine 
dysfunction. Few features are : 
1. Delayed body growth resulting in Pituitary Dwarfism. 
2.  Adiposogenital Dystrophy (Frohlich’s Syndrome). 
3.  Sexual Disturbances such as amenorrhoea, loss of libido , 
impotency and gonadal atrophy. 
4.   Reduced hair growth 
5.  Intolerance to cold temperature. 
6.  Weight gain. 
7.  Cachexia (Simmonds disease). 
8.  Decreased BMR. 
9.  Dryness and Atrophy of Skin. 
10.  Tendency of hypoglycaemia. 
If there is hypothalamic involvement it can result in imbalance of 
thermoregulation, diabetic insipidus and somnolence. 
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Pituitary Adenomas  
The characteristic pituitary tumor is the adenoma. Uncommon in 
children, its incidence increases with age and may approach 30% in an 
older population. Pituitary adenomas constitute 12-15% of all 
symptomatic intracranial tumors. Most are sporadic. As a pituitary 
adenoma grows and extends beyond the sella turcica, it may then impinge 
upon the visual pathways, especially the chiasm, and the ocular motor 
cranial nerves in the cavernous sinus  
Types of Pituitary Adenomas 
Pituitary adenomas are arbitrarily grouped by size into  
 microadenomas (less than 10 mm in greatest diameter) and  
 macroadenomas(>10mm) 
They are also classified according to their secretory function, 
although a single tumor may secrete more than one hormone. Many 
tumors that secrete hormones prolactin, growth hormone (somatotrophin), 
adrenocorticotropic hormone (ACTH or corticotrophin), and thyroid-
stimulating hormone (TSH) present clinically as endocrinopathies. As a 
result, secreting tumors are often diagnosed while still microadenomas. 
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Non secreting tumors are usually recognized when they have 
grown large enough to produce visual symptoms or headache, thus 
tending to present as macroadenomas.  The widespread use of imaging 
has led to the discovery of silent microadenomas, termed incidentaloma, 
measuring as small as 2-3 mm and present in 10-20% of the general 
population.  
The prevalence of microadenomas at autopsy may be as high as 
30%. The imaging procedure of choice in the detection of 
parasellartumors, including pituitary adenomas, is high-field magnetic 
resonance (MR) imaging performed both with and without gadolinium. 
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THE CHIASMA 
Optic chiasma is the most important structure as the arrangement 
of fibres accounts for the characteristic defects. It is a flattened structure 
which is 12mm horizontally and 8mm antero-posteriorly and is 8 to 10 
mm above the hypophysis cerebri .It is ensheathed by the piamater and is 
surrounded by the CSF.As it is related to the pituitary gland below 
appearance of a visual defect in the patient indicates a suprasellar 
extension. Posteriorly it continuous as the optic tracts. At the chiasma 
there is a hemi decussation or crossing over of nasal fibers to the opposite 
tract . 
 
Figure 3: relations of chiasma 
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There are variations in the location of the chiasma in relation to the 
pituitary gland .In 80% it lies directly above the chiasma where the 
expansion of tumour can affect the chiasma first .In 10% it is located 
anteriorly over the tuberculum sellae which is called a prefixed chiasma 
where in optic tracts are affected first .In remaining 10%(post fixed) it 
lies more posteriorly over tuberculum sellae .  
 
 
Figure 4: types of chiasma 
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Relations of chiasma 
Anteriorly related to anterior cerebral and anterior communicating 
arteries and posteriorly, to Tuber cinerum, infundibulum mammillary 
body and posterior perforated substance It is superiorly related to the 
third ventricle, inferiorly to the hypophysis, laterally the internal carotid 
artery and anterior perforated substance.
  
 
Vascular supply 
The anterior cerebral and anterior communicating arteries supply 
the superior aspect of chiasma. Internal carotid artery, anterior 
 20 
hypophyseal artery and posterior communicating artery supply the 
inferior aspect. 
The superior aspect is drained by superior chiasmal vein which 
drains into anterior cerebral vein and the pre-infundibular vein drains the 
inferior aspect of the chiasma. 
According to Bergland and Ray, arteries at the chiasma can be 
divided into superior and inferior arteries. The inferior group supplies the 
decussating axons, thus any pituitary adenoma is more likely to compress 
this inferior division leading to the visual field defects. The superior 
group supplies the undecussated axons which occupy the lateral portion 
of the chiasma. Unless the size of the adenoma is large these axons 
remain unaffected. But another school of thought says that the arterial 
perfusion pressure is more when compared to the compression caused by 
the adenoma thereby suggesting that the arterial supply at the chiasma has 
no role in affecting the decussating fibres. 
Hermann Willebrand in 1904, proposed that a group of inferonasal 
extramacular ganglion cell axons loop anteriorly into contralateral optic 
nerve (Willebrand’s knee) 
 21 
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OPHTHALMIC MANIFESTATIONS 
Presentation is typically during early adult adulthood or in the 
middle age .Chromophobe adenoma is the most common primary 
intracranial tumors to present with neuro-ophthalmic features. They are 
usually first presented to an endocrinologist,however non secreting 
tumors may present to ophthalmologists. 
HEADACHE 
The nerve fibers of diaphragma sellae are sensitive to pain and thus 
headache presents as a prominent and a common presenting complaint. 
Headache is usually a non specific complaint and is very rarely related to 
raised intracranial pressure due to extension of the tumor. This is the 
reason behind diagnostic delay in such cases where there are no obvious 
endocrinological signs. 
The onset of visual symptoms are gradual as patient may be 
aymptomatic until well established. This obviates the need for a careful 
visual system examination in every case of non specific headache. 
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Chiasmal Field Defects 
Pituitary adenomas usually compress the chiasm from below. The 
visual field defect most often produced is superior, bitemporal, and 
greater nearer fixation. While the macula represents only a small area on 
the retina, axons arising from macular ganglion cells occupy large 
portions of the optic nerves, chiasm, and optic tracts. One consequence is 
that compression of either the optic nerve or chiasm tends to reduce 
acuity and to depress the central field. Loss of stereopsis may be an early 
sign of chiasmal compression and bitemporal scotomatous field loss. 
Fris divided chiasmal visual field defects into medial and lateral 
syndromes. Medial chiasmal syndromes have predominately bitemporal 
field defects, and lateral chiasmal syndromes have temporal field defects 
on the side of the tumour and another type of field defect in the fellow 
eye. Acuity in medial chiasmal syndromes is reduced in both eyes, often 
asymmetrically. In lateral chiasmal syndromes, the acuity may be reduced 
only in the eye with the temporal field defect. 
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Figure 5:Pituitary macroadenoma 
 
Figure 6:Progression of bitemporal visual field defects 
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Monocular Visual Field Defects 
The occasional patient with sudden visual loss in one eye as the 
result of a pituitary adenoma once ran the risk of being misdiagnosed 
with retrobulbar optic neuritis. As virtually everyone with the putative 
diagnosis of optic neuritis now undergoes MR imaging to look for 
evidence of demyelination as a guide to immune modulation therapy, this 
should seldom be an issue. Sudden monocular visual loss may be the 
presentation of pituitary apoplexy. When such patients are evaluated 
emergently, careful testing of the visual field of the fellow eye may not be 
performed. Monocular visual field defects were detected in 9% of the 
1,000 patients with adenomas in the Mayo Clinic series published in 1973 
and in 38.7% of 307 cases of acromegaly evaluated in a Paris referral 
center between 1951 and 1996. In both series, a supertemporal 
quadrantanopia was the most common monocular defect. 
Caution should be exercised in attributing a monocular temporal 
hemianopia to chiasmal dysfunction, as this is a common pattern of 
functional (psychogenic) visual loss. A functional etiology should be 
considered likely when there is no relative afferent pupillary defect or 
optic atrophy and may usually be confirmed by the persistence of the 
hemianopia on binocular testing. 
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Junctional Defects 
One pattern of field loss whose localizing value is still a matter of 
discussion is a central scotoma in one eye associated with temporal field 
loss in the other, a combination thought to point to the junction between 
the optic nerve and the chiasm on the side of the scotoma. Traquair called 
attention to the hemianopic quality of the scotoma and used the phrase 
junction scotoma. An isolated, monocular temporal hemianopic 
paracentral scotoma is thus sometimes referred to as a junctional scotoma 
and may be the presentation of a pituitary adenoma. 
 
Figure 7 :junctional field defect 
Traquair also attributed to Wilbrand and Saenger the observation 
that involvement of the knee of crossed fibers from the opposite nerve 
may be the source of a temporal defect in the opposite field. In a patient 
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with pituitary adenoma described by Karanjia and Jacobson with a central 
scotoma in one eye and a temporal field defect in the fellow eye 
localizing to the prechiasmatic optic nerve, Horton pointed out that 
careful review of their imaging actually reveals anterior chiasmal 
compression. In another  reported instance of what could be interpreted as 
a junctional defect, imaging demonstrated a large mass extending out of 
the sella and compressing the chiasm. 
Independent of the actual existence of knee fibers, the value of a 
central scotoma in one eye associated with a temporal field defect in the 
fellow eye should direct attention to the posterior optic nerve where it 
joins the chiasm. This pattern is less often encountered with pituitary 
adenomas than with other pathologies, such as meningioma, aneurysm, 
and inflammation. 
Ophthalmoplegia 
Third, fourth, and sixth nerve palsies individually and in 
combination are less common than optic nerve involvement in pituitary 
adenomas but still constitute an important clinical manifestation. As an 
isolated motor neuropathy, third nerve involvement is most frequent and 
may be painful. 
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Figure 8: Parachiasmal structures 
Parachiasmal vascualr structures  
Cavernous sinus: an expanding hypophyseal tumor can invade 
laterally into cavernous sinus and thus involve cranial nerves .Conversely 
aneurysms from intracavernous internal carotid artery can also erode sella 
and can mimic pituitary adenoma 
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Figure 9 : Relation of pituitary with cavernous sinus 
Pituitary Apoplexy 
Headache, ophthalmoplegia with or without visual loss, and 
alteration in consciousness suggest sudden enlargement of a pituitary 
adenoma as the result of hemorrhage or infarction, an entity known as 
pituitary apoplexy. Pituitary apoplexy may also present with visual loss 
alone or in association with Horner's syndrome. Precipitating factors 
include head trauma, treatment with radiation or bromocriptine, estrogen 
administration or pregnancy, angiography, anticoagulation, cardiac or 
other recent surgery, dialysis, dynamic pituitary function or stimulation 
tests, and transient changes in intracranial pressure (ICP) from coughing 
or sneezing or spinal anesthesia. The majority, however, have no 
identifiable precipitant. 
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To evaluate a sudden, severe headache ,CT is usually performed 
without contrast, looking for subarachnoid hemorrhage. This may or may 
not lead to immediate recognition of the adenoma. CT, although usually 
more readily available than MR imaging, is not as sensitive as MR 
imaging in the diagnosis of pituitary apoplexy. 
COLOUR DESATURATION 
A colour desaturation especially in one half of the visual field 
across the vertical midline is an early detector of chiasmal compression. 
This can be tested easily with a red pen tip ,with each eye tested 
separately and asking the patient to compare the colour and intensity as 
the tip is moved across his nasal to temporal field or by simply asking the 
patient to compare the intensity of 2 red targets presented in nasal and 
temporal fields .If the patient fails to appreciate ,we can test on an 
Ishiharas chart. 
Optic atrophy 
This can present in 50% of cases caused by direct compression by 
pituitary adenomas. Such patients have complaints of defective central 
vision when compared to peripheral vision, hence present with 
complaints of difficulties in reading. It becomes important to explain a 
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guarded visual prognosis after treatment in such patients.When the 
compressing tumor affects only the nerve fibers originating in the nasal 
retina, only the nasal and the temporal aspect of optic disc is involved. 
This results in a  band or a “Bow Tie atrophy “. 
 
Figure 10: Bow tie optic atrophy 
Hallucinations, Papilledema, and Other Visual Manifestations of 
Pituitary Adenomas 
Virtually any sign or symptom that can be produced by damage to 
the anterior visual pathways and adjacent structures may be encountered 
in patients with pituitary adenomas. These include formed and unformed 
hallucinations, transient monocular blindness, and mental status changes. 
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Papilledema is unusual with pituitary adenomas as the axonal loss 
caused by direct compression results in optic atrophy before the tumour is 
of sufficient size to increase ICP. If tumour growth is asymmetric, the 
Foster-Kennedy syndrome may ensue. Bilateral disc swelling from 
malignant hypertension associated with Cushing's disease mimics true 
papilledema. 
EXTENSIVE LOSS OF TEMPORAL FIELD 
This can impair the sensory fusion and decompensate a phoria or 
cause problems with near vision .Post fixation blindness refers to the 
presence of a blind spot distil to the fixation point. 
Diplopia Without Ophthalmoplegia 
While the vast majority of patients with pituitary adenomas who 
complain of diplopia have ophthalmoplegia, some have normal ocular 
motility. This phenomenon, known as non paretic diplopia or hemifield 
slide, occurs when the degree of temporal visual field loss lessens the 
stabilizing effect of overlap with the contralateral eye's nasal field. 
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Figure 11: Hemifield slide phenomenon 
  This is probably the same mechanism that decreases stereopsis.  
SEE SAW NYSTAGMUS 
Loss of sensory input may be important in some cases of seesaw 
nystagmus, a rare ocular oscillation where the eyes appear to be riding on 
a seesaw across the nose. One eye elevates and intorts while the other eye 
is synchronously depressing and extorting, then the cycle reverses. 
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Figure 12: See saw nystagmus 
  Parasellar tumors, including pituitary adenomas, are accompanied 
by seesaw nystagmus on rare occasions, and one postulated mechanism is 
compression of the diencephalon in the region of the interstitial nucleus 
of Cajal. Usually these are large tumors with accompanying bitemporal 
field defects. 
Photophobia 
Intolerance to light is a symptom of many disorders, from ocular 
surface disease to migraine. Photophobia is a common feature of 
trigeminal neuralgia and may be prominent in patients with chiasmal 
compression. 
16 
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Visual field patterns 
Neuro-Ophthalmologists can challenge at one point regarding the 
accurate diagnosis for neurological cases when it is at the level of optic 
chiasma. The  detection and in interpretation of visual field defects at the 
level of optic chiasm will become more easy if the following factors are 
taken into account.  
 Chiasmal fibre architecture and its vascular supply  
 Normal Variation of chiasma to Pituitary Body 
 Relation of Optic Chiasma to surrounding structures 
Direction of Pressure and pressure effect of the tumor on the 
chiasma is not directly on the nerve fibres but on the blood vessels 
producing ischemia. 
Visual field assessment is a method of plotting the boundaries of 
visual field and determining whether the field within the peripheral 
boundaries is intact. 
History of visual field 
 Marriotte in seventeenth century was the first to document a blind 
spot 
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 Young and Purkinje were the first to assess the peripheral 
boundaries of fields. 
 Von Grafe was the first to clinically measure the visual fields 
 Bjerrum, in 1889, introduced a tangent screen for assessing visual 
fields. 
 Aimark in 1930 ,introduced arc perimeter 
 Goldmann perimeter was introduced in 1945 
 In 1970s, automated perimeters were introduced, with subsequent 
development of different types and many testing programs 
Visual fields serve three important purposes: 
 Diagnostic: Visual field defects indicate involvement of the visual 
pathways and the pattern of visual field defects help in localizing 
site of the lesion. 
 Follow-up: Visual fields provide an excellent tool to monitor 
resolution and/or recurrence of disease processes affecting the 
visual pathways. 
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 Activities of daily living: Since visual field defects adversely affect 
the patient’s ability to perform day-to-day activities such as 
personal hygiene, reading, and driving, these defects should be 
actively sought when planning rehabilitation strategies.  
 Neuro-ophthalmic examination reaches a maximum importance 
with tumors of pituitary gland not so only because it permits exact 
localization, but because the symptoms produced by these tumours 
in the initial as well in the fully developed stage are ocular 
symptoms .Hence sooner or later ,these symptoms will bring the 
patient to the ophthalmologist 
 In addition to the characteristic bitemporal Hemianopia few less 
pathognomonic forms for instance – Field loss may progress 
rapidly in one eye with amaurosis and a temporal hemianopia in its 
fellow eye can occur. Therefore, temporal hemianopia should be 
evaluated with great caution. 
AFFERENT VISUAL PATHWAY 
A 3 dimensional map of the visual sensitivity across the visual field 
is called as hill of vision. 
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 The highest area of sensitivity corresponds to the fovea. Towards  
the periphery the sensitivity decreases. The extent of the monocular 
visual field extends 90 to 100 degrees temporally,70 to 75 degrees 
inferiorly,60 degrees nasally and 50 to 60 degrees superiorly. 
 The visual field is the perceived vision ,produced by the retinal 
stimulation of each eye, whilst maintaining a fixed steady fixation. 
 Retinal images are projected to a position opposite to the area of 
stimulated retina. 
 Most of the nerve fibres that arise from the macular region ,directly 
pass directly to the optic disc ( papillo macular bundle) 
 The peripheral temporal fibres ,arc above and below the macula to 
enter the disc .Nasal nerve fibres enters the disc directly on the 
nasal side of the disc. 
 In the optic nerve the macular fibres are in the centre with superior 
and inferior fibres around it. 
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 In the optic chiasm, nasal nerve fibres decussate while temporal 
fibres pass on to the ipsilateral optic tracts. 
 In the optic tract, ipsilateral temporal nerve fibres with 
contralateral nasal nerve fibres regroup, 
 In lateral geniculate body, there is a more complicated, multilayer 
arrangement, with macular fibres distributed throughout the 
nucleus. 
 From the lateral geniculate body, fibres fan out forming the optic 
radiation to directly reaching the posterior visual cortex. 
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Figure showing afferent visual pathway 
Altitudinal field defect  
Involvement of any two quadrants either superior or inferior 
respecting the horizontal meridian, which is a characteristic finding in 
ischemic optic neuropathy. As the superior or inferior fibers in the region 
nasal to optic disc and temporal to macula is clearly demarcated they 
respect the horizontal meridian. 
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Arcuate field defect 
  Selective damage to the superior and inferior fibers as they enter 
into the optic nerve result in an arcuate defect which is a common feature 
of glaucoma. Such defects are also seen in ischemic optic neuropathy, 
optic neuritis etc. 
Hemianopia 
A hemianopia involves one complete half of the visual field. It can 
be a nasal or a temporal hemianopia. It is said to be heteronymous when 
it involves the opposite sides of visual fields as seen in lesions 
compressing the chiasma resulting in a typical heteronymous bitemporal 
hemianopia. If a lesion involves the same side of the field in both eyes, as 
in case of retrochiasmal lesions it produces a homonymous hemianopia  
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Quadrantanopia 
It is a defect involving one fourth or one quadrant of a visual field 
.It can be homonymous or heteronymous can involve superior or inferior 
quadrants .They are seen in lesions of temporal, parietal occipital lesions . 
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OCTOPUS PERIMETER 
Perimetry is the study of visual fields. Visual field changes due to 
both glaucomatous and non glaucomatous causes can be evaluated and 
followed up using automated perimetry . 
Octopus perimeter was first introduced in 1970. DrFranz 
Funkhauser and his associates developed the original octopus model 201, 
which was one of the first reliable perimeters available. In the last few 
years improved and new softwares have been added. Octopus perimeters 
have established standards for the present day perimetry. 
In 1980s , octopus 2000 and octopus 500 were introduced. Later 
octopus 1-2-3 was introduced, which did not require any cupula as the 
stimulus was directly projected into the eye.in 1990s,Octopus 101 was 
introduced ,which was the first perimeter in windows ,it is very popular 
and is the most commonly used perimeter till date. 
THE PROECTION SYSTEM 
The 201,500 ,101and 2000 series  project their stimuli on a cupula 
or a bowl with a background illumination of 4 asb whereas in octopus 1-
2-3 the patient looks through a 3 inch port hole through which the stimuli 
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is directly projected into the eye.The stimuli appears to come from 
infinity to the patient. 
In octopus 1-2-3 the stimuli is generated by a single light emiting 
diode and the white halogen light maintains a background illumination of 
31.4 asb 
STIMULUS 
The target size used by Octopus machines is Goldmann target 3 for 
threshold and test screening. Goldmann size 5 can be used in patients 
with decreased vision .the stimulus duration is 100 ms and the machine 
gives the patient two seconds to respond to each stimulus .Further, the 
machine adjusts to patient’s response time .The stimulus intensity ranges 
between 4000 to 0.4 asb. 
FIXATION MONITORING 
A 100 percent fixation control is maintained by octopus , as it has a 
unique fixation control system. Once the patient is positioned ,the centre 
of the patients pupil is projected on the display screen by aligning the 
perimeter .this fixation control monitor is electronically controlled .if the 
patient looses fixation it automatically stops projecting stimuli, resumes 
when the fixation is back on the target. The operator is signalled if the 
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fixation is lost for 3 seconds. If the patient blinks during the stimulus 
projection the machine repeats the stimuli. 
The patients threshold it is defined as the stimulus luminance 
which is perceived for a given background illumination with a probability 
of 50% chance of seeing or non seeing which is described by the 
frequency of seeing curve as function of stimulus luminance. 
Octopus perimeter has 2 models:  
1. cupola type (101 and 900)   
2.  infinity projection system (123 and 300 series)  
 
Figure 13: Octopus 300 
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The octopus 300 uses a 
 Background luminance of 31.1asp. 
 Stimulus size can be either Goldmann 3 or 5  
 Duration of 100 ms   
 Threshold range measuring 0 to 40 decibels 
The test strategies can be :4-2-1 decibel bracketing/Dynamic 
strategy/Tendency oriented perimetry(TOP). These minimize the test 
duration decreasing the effects of physical and retinal fatigue. 
TOP strategy 
Tendency oriented perimetry was introduced by Prof Gonzallez De 
La Rosa .TOP strategy takes into account the neighbouring test locations 
when the results are interpreted. The neighbouring zones exhibit a 
topographical interdependence ,which establishes a tendency between an 
adjacent points under examination. In TOP strategy each test location is 
assessed only once and this response to a single location is used to assess 
not only the sensitivity at that point but assess the sensitivity of 
neighbouring locations.This estimates one direct response and 4 indirect 
response from the neighbouring locations.The advantage of this is that it 
 47 
reduces the test time to 2.5 to 3 minutes ,but it can underestimate the 
extent of localised defect. 
Program 32 
This is the classic off axis program introduces by octopus and later 
by other perimeters as the 32-2 program. There are 76 test locations in a 
grid pattern with resolution of 6 degrees. This program is not related to 
the topography of the nerve fiber layer or pathology with both eyes 
having identical pattern of test locations. In neurological cases it gives a 
better definition of vertical and horizontal meridia .The area where the 
blind spot appears ,marks the right and left eye. 
N 1 program 
The N1 neurological program is a multistep examination program 
which takes inti account the possible displacement of blind spot due to 
extraocular muscle and avoids artifacts due to hemianopia or hemi 
neglect. 
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RADIOLOGICAL IMAGING OF PITUITARY 
ADENOMAS 
 
 Magnetic resonance imaging 
It is an optimal study to demonstrate the anatomical relationship 
between chiasma and pituitary gland. Ideally a corona, sagittal and an 
axial thin sections before and after gadolinium is necessary for the study 
of sellar contents. A  coronal plane is optimal.Adenomas appear 
hypointense on T1, hyperintense on T2 and strongly enhance on 
gadolinium heterogeneously 
.  
Figure 14:MRI showing pituitary adenoma 
 Computerized tomography 
Usually used to demonstrate erosion of sella due to enlargement of 
tumour. 
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Radiographic features 
Pituitary macroadenomas are by definition >10 mm mass arising 
from the pituitary gland, and usually extending superiorly. Indentation at 
the diaphragma sellae can give a snowman or figure eight 
configuration 
10
.  
CT 
No contrast attenuation can vary depending on haemorrhagic, 
cystic and necrotic components. Adenomas which are solid, without 
haemorrhage, typically have attenuation similar to brain (30-40 HU) and 
demonstrates moderate contrast enhancement; less marked than one 
typically sees in meningiomas. Calcification is rare. 
MRI 
MRI is the preferred imaging modality, not only able to exquisitely 
delineate the mass, but also clearly visualise the optic chiasm, anterior 
cerebral vessels and cavernous sinuses.  
Overall signal characteristics can significantly vary depending on 
tumour components such as haemorrhage, cystic transformation or 
necrosis. 
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 T1 
o typically isointense to grey matter 
10
 
o larger lesions are often heterogeneous and vary in signal due to 
areas of cystic change/necrosis/haemorrhage 
 T1 C+ (Gd) 
o solid components demonstrates moderate to bright enhancement 
 T2 
o typically isointense to grey matter
 10
 
o larger lesions are often heterogeneous and vary in signal due to 
areas of cystic change/necrosis/haemorrhage 
 T2* gradient echo 
o most sensitive for detecting any haemorrhagic components, which 
appear as areas of signal loss 
o calcification is rare, but should be excluded by reviewing CT scans 
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Assessment of cavernous sinus invasion can be difficult. The most 
convenient method is to assess the degree of encasement of the cavernous 
portion of the internal carotid artery. Less than 90 degrees makes 
involvement of the sinus very unlikely, whereas greater than 270 degrees 
makes involvement almost certain 
10
.  
PET 
Normal pituitary gland should not demonstrate significant FDG 
uptake and are normally not seen on PET-CT
12
. Pituitary macroadenomas 
are highly hypermetabolic both with FDG and Choline tracers. 
Differential diagnosis 
The differential of a pituitary macroadenoma is essentially the list 
of conditions leading to a pituitary region mass. The most common 
considerations include: 
 pituitary metastasis 
o often in the setting on known disseminated malignancy 
o often less well defined 
o bone destruction rather than remodelling may be seen 
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 pituitary carcinoma 
o indistinguishable on imaging 
o CSF seeding may be evident 
o rare 
 meningioma 
o separate pituitary is usually identifiable  
o dural tail usually visible 
o enhancement more vivid 
o hyperdense on non-contrast CT 
 craniopharyngioma (papillary type) 
o adamantinomatous craniopharyngiomas are more common in 
children 
o more likely to be cystic and to have areas of calcification 
(although still a minority of cases) 
o more likely to have areas of T1 intrinsic hyperintensity 
(although blood can result in similar appearances) 
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 lymphocytic hypophysitis 
o common in peripartum female 
 saccular cerebral aneurysms  
o flow void common on MR; CTA can show flow 
o more likely to have calcification 
 
MR T1 weighted gadolinium enhanced image of a pituitary adenoma 
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AIM OF THE STUDY 
PRIMARY OBJECTIVES 
 To study the various ophthalmic manifestations in cases of 
pituitary tumors. 
 To analyse the proportion of cases presenting with ophthalmic 
manifestations in cases diagnosed as pituitary adenoma on 
radiological imaging. 
SECONDARY OBJECTIVES 
 To analyse the sensory visual disturbances like degree of visual 
loss, pattern of visual field defects and ocular motility defects, in 
diagnosed cases of pituitary adenomas. 
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MATERIALS AND METHODS 
Patients who are diagnosed with pituitary adenoma on radiological 
imaging, presenting in Squint and Neuro-ophthalmology services will be 
registered and evaluated during the study period. 
A detailed history of the patient, evaluation of visual acuity on a 
Snellen chart, extraocular movement and pupillary assessment, colour 
vision, visual field examination by 32 program on octopus field analyser 
octopus, slit lamp examination, and fundus examination will be done. 
INCLUSION CRITERIA 
1.  Patients diagnosed as having pituitary tumour on radiological 
imaging 
2. Age 25- 65 years. 
EXCLUSION CRITERIA 
1. Patients with other ocular pathologies affecting visual fields such 
as glaucoma, optic neuritis, retinitis pigmentosa. 
2. Patients with pre-existing defective vision to due to other causes. 
3. Patients with ocular media opacities 
4. Patients physically or mentally unfit for detailed ocular 
examination  
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SCREENING PROCEDURE 
After taking an informed consent from the patient the following 
screening procedures were done  
1. Detailed history of present illness, headache evaluation 
2. Head posture 
3. Extraocular movements, diplopia charting 
4. Visual acuity using Snellen’s acuity chart 
5. Colour visionby Ishihara’s Pseudoisochromatic chart 
6. Slit lamp biomicroscopy of anterior segment 
7. Pupillary assessment to look for RAPD 
8. Visual field examination using 32 program on the octopus field 
analyser 
9. Intraocular pressure using Goldmann Applanation tonometer 
10. Sterepscopic examination of the optic disc and nerve fibre layer 
using a +90D lens with the slit lamp 
11. Indirect ophthalmoscopy 
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OBSERVATION AND ANALYSIS 
1. Age distribution 
Age Frequency Percentage 
10-20 1 4 
21-30 0 0 
31-40 4 16 
41-50 5 20 
>50 15 60 
 
 
Figure 15 
In the present study of 25 patients ,15 patients (60%) were above 
the age of 60 years, followed by 5 patients in the age group between 41 to 
50 years , 4 patients were in the age group of 31 to 40 years and one 
patient was below 20 years. 
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2. Gender distribution  
Gender Frequency Percentage 
Male 7 28 
Female 18 72 
Total 25 100 
 
 
Figure 16 
In our study females were predominantly affected (76%) when 
compared to males (28%) 
  
Male 
28% 
Female 
72% 
Gender distribution in patients studied 
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3. Visual acuity of patients studied: 
Best corrected Visual Acuity 
 
 
6/6 to 
6/12 
6/18 to 
6/36 
<6/60 Total 
Right Eye Frequency 16 6 3 25 
Percentage 64 24 12 100 
Left Eye Frequency 15 8 2 25 
Percentage 60 32 8 100 
Total Frequency 31 14 5 50 
Percentage 62 28 10 100 
 
 
Figure 17 
Out of 25 patients studied 62% had visual acuity between 6/6 to 
6/12 on presentation. 
28% of patients had a visual acuity between 6/18 to 6/36 and only 
10% had an acuity below 6/60  
6/6 to 6/12  
62% 
 
6/18 to 6/36  
28% 
<6/60  
10% 
Distribution of Visual Acuity 
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4. Mode of presentation 
Chief Complaints Frequency Percentage 
Head Ache 20 80 
Defective Vision 4 12 
Diplopia 1 4 
Total 25 100 
 
   
Figure 18 
Headache was the predominant symptom in most of the patients 
(80%) 
Four (12%)  patients presented with complaints of defective vision 
and 1( 4% ) patient had complaints of diplopia 
  
Head Ache, 
80 
Defective 
Vision, 12 
Diplopia, 4 
Mode of presentation of patients 
with Pituitary Adenoma 
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5. Distribution of pattern of visual field defects: 
 
Figure 19 
Normal 
6 
24% 
Defective 
19 
76% 
Visual Fields 
Normal Defective
 62 
 
 
 
Figure 20 
  
0 2 4 6 8 10 12
Bitemporal Heminanopia
Non Specific Changes
One Eye Blind and Contralateral Temporal
Hemianopia
One Eye Temporal Hemianopia , Other Eye
Superotemporal Quadrantanopia
One Eye Temporal Hemianopia , other Eye
involvement of 3 quadrants
Fields not Possible(Poor Visual Acuity)
Patterns of Visual Field defects 
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Visual Fields Frequency Percentage 
Bitemporal Heminanopia 11 57.9 
Non Specific Changes 2 10.5 
One Eye Blind and Contralateral Temporal 
Hemianopia 
2 10.5 
One Eye Temporal Hemianopia , Other Eye 
Superotemporal Quadrantanopia 
1 5.3 
One Eye Temporal Hemianopia , other Eye 
involvement of 3 quadrants 
2 10.5 
Fields not Possible(Poor Visual Acuity) 1 5.3 
Total 19 100.0 
 
Out of 25 patients studied in the present study,76% showed field 
defects and the remaining 24% had no field abnormalities. The most 
common visual field defect was bitemporal hemianopia 57.9%).10.5% of 
patients presented with one eye blind and contralateral temporal 
hemianopia 
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6. Number of patients with different types of adenomas 
Radiological 
Diagnosis 
Frequency Percentage 
Pituitary 
Macroadenomas 
24 96 
Pituitary 
Microadenomas 
1 4 
Total 25 100 
 
 
Figure 21 
Out of 25 cases of radiologically diagnosed cases of pituitary 
adenomas studied, 24 cases were macroadenomas and the remaining 1 
case was microadenoma. 
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7. Fundus Examination findings in Patients diagnosed with 
pituitary adenomas 
 
 
Figure 22 
Of the 25 cases 4 cases showed features of optic atrophy on 
ophthalmoscopic examination of the fundus and the remaining cases were 
normal  
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DISCUSSION AND RESULTS 
The present study titled “A study on ophthalmic manifestations in 
pituitary gland tumors” was conducted on 25 patients who were 
radiologically diagnosed cases of pituitary adenoma and were evaluated 
for various ophthalmic manifestations .25 patients were recruited in our 
study according to the inclusion and exclusion criteria. 
In the present study, among the 25 patients the vulnerable age 
group were those above the age of 50 years (60%), followed by age group 
of 41 to 50 years (20%).The mean age at which the pituitary adenoma 
was diagnosed was determined as  50.68   years. 
The observations regarding the mean age at which pituitary 
adenoma was diagnosed is in agreement with the mean age of 45.8+/-15.6 
years (range 19 to 86 years) reported by Jung Pil Lee,Yun Suk 
Chung(2011)
22.
 
In the reports of Thomas et al (2002)
14
, pituitary adenomas were 
diagnosed in patients of the age group 16 to 69 years and the mean age 
was reported as 45 years. 
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Khalid et al(2010)
25
 reported that the vulnerable age group was 30 
to 49 years and the mean age at which the pituitary adenoma was 
diagnosed was 42.92 years. 
In another study ( Elgamal et all 2007 
24
), a mean age of 42 years 
was observed with a range of 14 to 85 years among 62 patients. 
          However, Dhasmana et all (2011)
15
 reported that among 18 patients 
in which pituitary adenoma was diagnosed, the mean age at the time of 
diagnosis was slightly lower than the results observed in the present study 
(35.1+/= 9 years) 
           In the present study, out of 25 patients enrolled, 72% were females 
and 28% were males. 
Thus there was a predominance of females in diagnosed cases. 
          A higher incidence of pituitary adenomas in females has also been 
reported by Khalid et al (2010)
25 
who reported that the incidence in 
females was about 4 times higher than in males. 
A similar higher incidence in females is reported from the studies 
made at king Saud university by Elgamal et al (2007)
24 
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          In contrast Thomas et al(2002)
14
,reported the incidence of pituitary 
adenomas to be 2 times higher in males as compared to females. 
However, Dhansama et al (2011)
15
 observed that the incidence of 
pituitary adenoma was only slightly higher in males (55.5%) as compared 
to females (45.5%) 
In view of these conflicting reports, it becomes difficult to assess 
whether the incidence of pituitary adenoma is influenced by the gender. A 
study involving a larger number of patients would probably give a true 
picture. 
In the present study, among 25 patients studied, the chief 
presenting complaint was headache (80%).This observation indicated that 
every patient presenting with a complaint of non-specific headache 
showed have a detailed ophthalmic evaluation. Four patients (12%) gave 
complaints of defective vision and 1(4%) had diplopia. This observation 
indicates that cases of pituitary adenoma can also result in 
ophthalmoplegia, although at a lower frequency. Oculomotor nerve palsy 
was also reported by Saul, Robert et al, JAN2011 in 4 out of 5 patients as 
the only neurological manifestation of pituitary adenoma.  
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Of the 50 eyes studied, 62% of patients had a visual acuity between 
6/6 to 6/12 followed by 28% with visual acuity of 6/18 to 6/36 and the 
remaining 10% had a visual acuity of less than 6/60. 
Thomas et al (2010)
14
 also stated that visual acuity was normal in 
64.52% of the patients with Pituitary Adenomas. A normal visual acuity 
was also observed in 61.3% of the patients with Pituitary Adenomas 
examined at King Saud University (Elgamal et al 2007).
24 
Dhasmana et al (2011)
15
 in the study observed that among 18 
patients (36 eyes), 28 eyes (77.78%) had normal visual acuity (6/6-6/12) 
Meenakshi and Niranjan (2011) reported that in the study on 57 
cases – 54.38 %(62 eyes) had a visual acuity of 6/6. 
The observations made in present study as well as in the earlier 
reports seem to suggest that visual acuity remains normal in nearly 2/3
rd
 
of the patients with Pituitary adenomas and therefore is not a significant 
ophthalmological manifestation in patients with Pituitary adenomas. 
In the present study visual field defects were observed in 76% (19) 
of patients. This incidence is similar to the observations made by Jung et 
al (2011) wherein the incidence of field defects in cases of Pituitary 
adenomas was reported as 74%. However Thomas et al (2002) observed 
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the field defects were present in a vast majority of patients with Pituitary 
adenomas(94.6%). Further typical field defects were observed in 74.2% 
of the patients while it was atypical in 20.4% of the cases. 
In patients with visual field defects, a little over 50%(57.9%) 
exhibited bitemporal hemianopia. The other field patterns observed were 
one eye blind with contralateral eye showing a temporal hemianopia 
(10.5%, 2 patients), temporal hemianopia in the one eye and a three-
quadrant involvement in the other eye(10.5%,2 patients) and one eye 
temporal hemianopia and contralateral eye superotemporal 
quadrantonopia(10.5%,2 patients). 2 patients showed non-specific field 
changes and the visual fielding was not possible in 1 patient due to poor 
visual acuity. However, in 24%(6 patients) of patients with pituitary 
adenoma, visual fields were normal. 
Jung et al (2011)
22
 in their study observed the incidence of field 
defect of 74%. bitemporal hemianopia was the most common field defect 
(22%) 
In a study conducted by Farooq et al (2010)
25
 52 of the total 100 
patients had field defects with bitemporal hemianopia being the 
commonest. 
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Dhasmana et al (2011)
15
 observed that in a total of 36 cases 24 
cases (66.67%) had visual field defects of which bitemporal hemianopia 
was the commonest pattern in 6 patients (33.33%) 
In another study conducted at King Saud University (Elgamal et al 
2007)
24
, 44.4% of cases of Pituitary Adenomas had visual field defects 
and bitemporal hemianopia was most common defect (69%). 
Neuro-ophthalmic examination reaches a maximum importance 
with the tumors of Pituitary gland not so much because it permits an 
exact localization but because the symptoms produces by these tumors in 
the initial as well as fully developed stage are ocular symptoms therefore 
sooner or later these symptoms will bring the patient to ophthalmologist. 
It should be emphasized that symmetrical progressive stages in the 
deterioration of the visual field of the two eyes are characteristic of 
Pituitary tumors. In addition, there are other less pathognomonic forms. 
The field loss for instance may progress more rapidly in one eye than the 
other as was observed in some cases in the present study. Such as 
amaurosis of one eye with a temporal hemianopia therefore should be 
evaluated with great caution. 
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Nevertheless, the present study clearly observed that visual field 
defect was the most significant manifestation in patients with Pituitary 
Adenomas and emphasizes the importance of ophthalmological 
evaluation in suspected cases of pituitary tumors. 
Among the 25 patients in the present study 24 were radiologically 
diagnosed to have pituitary macroadenoma constituting 96%(24 patients) 
and 4% (1 patient) had Pituitary microadenoma. 
Of the 25 cases in the present study 4 cases showed features of 
optic atrophy on ophthalmoscopic examination of the fundus and the 
remaining cases were normal. 
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SUMMARY 
 Commonest Age group was more than 50 years (60%). Mean age 
50.6 years. 
 Females were more commonly affected (72%) 
 Headache was the most common presenting complaint (80%) 
 Most of the Patients (62%) had visual acuity between 6/6 to 6/12. 
 Patients had Pituitary macroadenomas in 96% of cases compared to 
microadenomas. 
 Bitemporal hemianopia was the commonest visual field defect 
(57.9%) 
 24% of the patients had no visual field defect. 
 16% Patients had features of Optic Atrophy on Fundus 
examination.  
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CONCLUSION 
 As the primary goal in the management of pituitary adenoma 
revolves around restoration of visual loss, a neuro-ophthalmic 
evaluation is essential for early detection, planning  treatment and 
subsequent follow up. 
 Although a bitemporal visual field defect is a pathognomonic 
ophthalmic finding in cases of pituitary adenomas , various other 
clinical features like  headache, ophthalmoplegia, sensory visual 
disturbances, and other  field defects were also  noted in our study. 
Hence, a thorough clinical evaluation is warranted in pituitary 
adenomas. 
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Figure 23  Showing Bitemporal hemianopia 
 
Figure 24 showing RE superotemporal quadrantonopia and LE 
showing a temporal hemianopia 
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 PROFORMA 
NAME   
AGE/SEX  
I.P NO  
CHIEF COMPLAINTS 
TREATMENT HISTORY  
Medications 
Surgery 
PERSONAL HISTORY  
VISUAL ACUITY AT THE TIME OF EXAMINATION  
EXAMINATION:                 RE                                          LE 
HEAD POSTURE 
EXTRA OCULAR MOVEMENTS 
DIPLOPIA CHARTING 
VISUAL FIELDS  
COLOUR VISION 
 OTHER EXAMINATION  
LIDS  
CONJUNCTIVA  
CORNEA  
IRIS  
ANTERIOR CHAMBER  
PUPIL  
SWINGING FLASH LIGHT TEST :To detect RAPD 
LENS  
FUNDUS  
INTRA OCULAR PRESSURE  
INVESTIGATIONS  
CT/MRI    
Medical 
Surgical intervention 
 KEY TO MASTER CHART 
M  -  MALE 
F  - FEMALE 
RE  - RIGHT EYE 
LE  - LEFT EYE 
SYMPTOMS 
MOP   - MODE OF PRESENTATION 
COH  -  COMPLAINTS OF HEADACHE 
CODV -  COMPLAINTS OF DEFECTIVE VISION 
COD  -  COMPLAINTS OD DIPLOPIA  
COLV - COMPLAINTS OF LOSS OF VISION 
EXAMINATION 
BCVA -  BEST CORRECTED VISUAL ACUITY 
PL  -  PERCEPTION OF LIGHT 
CFCF  - COUNTING FINGERD CLOSE TO FACE 
NIP  - NO IMPROVEMENT WITH PIN HOLE 
NIG  -  NO IMPROVEMENT WITH GLASSES 
NP  - NOT POSSIBLE 
RTL  - REACTING TO LIGHT 
SRTL  - SLUGGISHLY REACTING TO LIGHT 
RAPD - RELATIVE AFFERANT PUPILLARY DEFECT 
